Sandhoff dieease is a variation of the rare and usually fatal genetic disorder Tay-Sachs disease, which causes progressive damage to the nervous system.
Timothy Cox's research group is working to develop gene therapy for children who have inherited Sandhoff disease.In the most common form of Tay-Sachs condition, symptoms usually begin at around six months of age, when a previously normal child's development begins to slow and they gradually lose their ability to move. Mainly it is in Sandhoff disease models that gene therapy and other enhancing treatments have been first tried; they respond well to gene therapy, which is also being extended to Tay-Sachs disease as well.
Cambridge owes its world-leading excellence in research and teaching to the generosity of its supporters. Our history is synonymous with a history of far-sighted benefaction, and the same is as true today as it has ever been.
Established as a charity in 1920, the Evelyn Trust makes grants to support medical research and health and wellbeing projects in Cambridgeshire. The Trust is particularly interested in research projects that have the potential to deliver transformational change, such as demonstration or pilot projects.